Paragon Care logo
PGC

Paragon Care

Health Care Equipment & Services

Paragon Care provides end-to-end healthcare solutions, encompassing equipment and service solutions for acute, aged, and primary care sectors. The company operates across four strategic pillars: Specialty Diagnostics, Specialty Devices, Capital and Consumables, and Service and Technology, delivering world-class technology and support across all healthcare sectors.

Short position

short percentage0.00%
reported shorts12.9K
shares on issue1.655B

Paragon Care (ASX:PGC) has 0.00% of its shares on issue reported as short positions as of 29 Sept 2026, or about 12,917 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 1.47% in March 2021. PGC is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Paragon Care (PGC) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$3.68B (source: ASX (Markit))vs $3.62B (source: ASX (Markit)) (FY25)
ASX (Markit), as at 1 Oct 2026
NPAT
−$16.0M (source: ASX (Markit))vs $20.6M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 1 Oct 2026
EPS (diluted)
−$0.010 (source: Derived: trailing 12 months at year end)vs $0.012 (source: Derived: trailing 12 months at year end) (FY25)
Derived: trailing 12 months at year end, as at 1 Oct 2026
Rev YoY
+1.8%FY
EPS YoY
n/mTTM
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of FY26 Annual Report, 23 Sep 2026

ParagonCare reported revenue of $3.7 billion for FY26, up 1.8%, and underlying EBITDA of $97.2 million, up 2.1%. No dividend was declared. The company expects continued inflationary pressures but is focused on sustainable earnings growth and stronger cash generation in FY27.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026

Gross margin
9.4%
Operating margin
0.2%
Net margin
−0.4%
FCF margin
−0.1%
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
0.2×
Cash dividends paid / net profit
n/a
Market cap
n/a (listed unit is not one ordinary share)
P/E
n/a (listed unit is not one ordinary share)
P/B
n/a (listed unit is not one ordinary share)

Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 1 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

PGC income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$3.68B (source: ASX (Markit))$3.62B (source: ASX (Markit))$2.97B$307.6M
Gross profit$347.5M (source: Derived: trailing 12 months at year end)n/a$176.5M$126.3M
Operating income$6.4M (source: Derived: trailing 12 months at year end)n/a$28.4M$24.1M
EBITDA$46.2M (source: Derived: trailing 12 months at year end)n/a$44.8M$37.1M
EBIT$9.0M (source: Derived: trailing 12 months at year end)n/a$30.3M$26.8M
Interest expense$30.6M (source: Derived: trailing 12 months at year end)n/a$16.2M$5.9M
Pretax income−$21.7M (source: Derived: trailing 12 months at year end)n/a$14.1M$20.9M
Tax−$5.6M (source: Derived: trailing 12 months at year end)n/a$5.7M$5.2M
NPAT−$16.0M (source: ASX (Markit))$20.6M (source: ASX (Markit))$8.4M$10.8M
Net interest income−$33.0M (source: Derived: trailing 12 months at year end)n/a−$16.2M−$6.6M
EPS basic−$0.010 (source: Derived: trailing 12 months at year end)n/a$0.009$0.016
EPS diluted−$0.010 (source: Derived: trailing 12 months at year end)$0.012 (source: Derived: trailing 12 months at year end)$0.009$0.016
Sharesn/an/a1.66B659.3M
  • ASX (Markit)
  • Derived: trailing 12 months at year end